Literature DB >> 29479122

MODELING LEFT-TRUNCATED AND RIGHT-CENSORED SURVIVAL DATA WITH LONGITUDINAL COVARIATES.

Yu-Ru Su1, Jane-Ling Wang2.   

Abstract

There is a surge in medical follow-up studies that include longitudinal covariates in the modeling of survival data. So far, the focus has been largely on right censored survival data. We consider survival data that are subject to both left truncation and right censoring. Left truncation is well known to produce biased sample. The sampling bias issue has been resolved in the literature for the case which involves baseline or time-varying covariates that are observable. The problem remains open however for the important case where longitudinal covariates are present in survival models. A joint likelihood approach has been shown in the literature to provide an effective way to overcome those difficulties for right censored data, but this approach faces substantial additional challenges in the presence of left truncation. Here we thus propose an alternative likelihood to overcome these difficulties and show that the regression coefficient in the survival component can be estimated unbiasedly and efficiently. Issues about the bias for the longitudinal component are discussed. The new approach is illustrated numerically through simulations and data from a multi-center AIDS cohort study.

Entities:  

Keywords:  Biased sample; EM algorithm; Likelihood approach; Monte Carlo integration; Semiparametric efficiency

Year:  2012        PMID: 29479122      PMCID: PMC5822752          DOI: 10.1214/12-AOS996

Source DB:  PubMed          Journal:  Ann Stat        ISSN: 0090-5364            Impact factor:   4.028


  9 in total

1.  Joint modelling of longitudinal measurements and event time data.

Authors:  R Henderson; P Diggle; A Dobson
Journal:  Biostatistics       Date:  2000-12       Impact factor: 5.899

2.  A semiparametric likelihood approach to joint modeling of longitudinal and time-to-event data.

Authors:  Xiao Song; Marie Davidian; Anastasios A Tsiatis
Journal:  Biometrics       Date:  2002-12       Impact factor: 2.571

3.  Joint modeling of survival and longitudinal data: likelihood approach revisited.

Authors:  Fushing Hsieh; Yi-Kuan Tseng; Jane-Ling Wang
Journal:  Biometrics       Date:  2006-12       Impact factor: 2.571

4.  Evaluating surrogate markers of clinical outcome when measured with error.

Authors:  U G Dafni; A A Tsiatis
Journal:  Biometrics       Date:  1998-12       Impact factor: 2.571

5.  A joint model for survival and longitudinal data measured with error.

Authors:  M S Wulfsohn; A A Tsiatis
Journal:  Biometrics       Date:  1997-03       Impact factor: 2.571

6.  The natural history of HIV infection in intravenous drug users: risk of disease progression in a cohort of seroconverters.

Authors:  G Rezza; A Lazzarin; G Angarano; A Sinicco; R Pristerà; L Ortona; M Barbanera; S Gafà; U Tirelli; B Salassa
Journal:  AIDS       Date:  1989-02       Impact factor: 4.177

7.  Modelling progression of CD4-lymphocyte count and its relationship to survival time.

Authors:  V De Gruttola; X M Tu
Journal:  Biometrics       Date:  1994-12       Impact factor: 2.571

8.  Random-effects models for longitudinal data.

Authors:  N M Laird; J H Ware
Journal:  Biometrics       Date:  1982-12       Impact factor: 2.571

9.  Disease progression and early predictors of AIDS in HIV-seroconverted injecting drug users. The Italian Seroconversion Study.

Authors: 
Journal:  AIDS       Date:  1992-04       Impact factor: 4.177

  9 in total
  3 in total

1.  Locally Efficient Semiparametric Estimators for Proportional Hazards Models with Measurement Error.

Authors:  Yuhang Xu; Yehua Li; Xiao Song
Journal:  Scand Stat Theory Appl       Date:  2015-11-06       Impact factor: 1.396

2.  Analyzing left-truncated and right-censored infectious disease cohort data with interval-censored infection onset.

Authors:  Daewoo Pak; Jun Liu; Jing Ning; Guadalupe Gómez; Yu Shen
Journal:  Stat Med       Date:  2020-10-21       Impact factor: 2.373

3.  Using statistics and mathematical modelling to understand infectious disease outbreaks: COVID-19 as an example.

Authors:  Christopher E Overton; Helena B Stage; Shazaad Ahmad; Jacob Curran-Sebastian; Paul Dark; Rajenki Das; Elizabeth Fearon; Timothy Felton; Martyn Fyles; Nick Gent; Ian Hall; Thomas House; Hugo Lewkowicz; Xiaoxi Pang; Lorenzo Pellis; Robert Sawko; Andrew Ustianowski; Bindu Vekaria; Luke Webb
Journal:  Infect Dis Model       Date:  2020-07-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.